Human prion disease and relative risk associated with chronic wasting disease

Emerging Infectious Diseases

Volumn 12, Issue 10, 2006, Pages 1527-1535

  MaWhinney, Samantha ^a   Pape, W John ^b   Forster, Jeri E ^a   Anderson, C Alan ^c,d   Bosque, Patrick ^c,e   Miller, Michael W ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b Colorado Department of Public Health and Environment ^*  (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

^f Colorado Division of Wildlife ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEATH CERTIFICATE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENDEMIC DISEASE; FEMALE; HUMAN; INFECTION RISK; MALE; PREVALENCE; PRION DISEASE; PUBLIC HEALTH;

EID: 33750025405     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1210.060019     Document Type: Article

References (37)

1. Williams ES, Young S. Chronic wasting disease of captive mule deer: A spongiform encephalopathy. J Wildl Dis. 1980;16:89-98.
2. Williams ES, Miller MW. Chronic wasting disease in North American deer and elk. Rev Sci Tech. 2002;21:305-16.
3. Williams ES, Miller MW. Transmissible spongiform encephalopathies in non-domestic animals: origin, transmission, and risk factors. Rev Sci Tech. 2003;22:145-56.
4. Williams ES, Miller MW, Kreeger TJ, Kahn RH, Thorne ET. Chronic wasting disease of deer and elk: a review with recommendations for management. J Wildl Manage. 2002;66:551-63.
5. Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis. 2004;10:977-84.
6. Prusiner SB. Neurodegenerative diseases and prions. N Engl J Med. 2001;344:1516-26.
7. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ, Larsen CT, et al. Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming. J Wildl Dis. 2000;36:676-90.
8. Spraker TR, Miller MW, Williams ES, Getzy DM, Adrian WJ, Schoonveld GG, et al. Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado. J Wildl Dis. 1997;33:1-6.
9. Alpers MP. Epidemiology and clinical aspects of kuru. In: Prusiner SB, McKinley MP, editors. Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic Press; 1987. p. 451-65.
10. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt CJ, Udy HJ, et al. Transmission dynamics and epidemiology of BSE in British cattle. [Erratum, Nature 1997;386:302]. Nature. 1996;382:779-88.
11. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature. 1997;388:285-8.
12. Raymond GJ, Bossers A, Raymond LD, O'Rourke KI, McHolland LE, Bryant PK III, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J. 2000;19:4425-30.
13. World Health Organization. WHO consultation on public health and animal transmissible spongiform encephalopathies: epidemiology, risk and research requirements. Geneva: The Organization; 2000. p. 52.
14. Belay ED, Gambetti P, Schonberger LB, Parchi P, Lyon DR, Capellari S, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol. 2001;58:1673-8.
15. Food and Drug Administration Transmissible Spongiform Encephalopathy Advisory Committee. Transcripts of open meeting, January 18, 2001, Bethesda, Maryland, USA [cited 20006 Aug 8]. Available from http://www.fda.gov/ohrms/ dockets/ac/01/transcripts/3681t2_02.pdf
16. Hamir AN, Cutlip RC, Miller JM, Williams ES, Stack MJ, Miller MW, et al. Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J Vet Diagn Invest. 2001;13:91-6.
17. Gould DH, Voss JL, Miller MW, Bachand AM, Cummings BA, Frank AA. Survey of cattle in northeast Colorado for evidence of chronic wasting disease: geographical and high-risk targeted sample. J Vet Diagn Invest. 2003;15:274-7.
18. Will RG. Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull. 1993;49:960-70.
19. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. Anew variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921-5.
20. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc Biol Sci. 1998;265:2443-52.
21. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature. 2000;406:583-4.
22. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect Dis. 2003;3:4.
23. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in Great Britain. Proc Biol Sci. 2003;270:689-98.
24. National Creutzfeldt-Jakob Disease Surveillance Unit. CJD statistics (June 2, 2006) [cited 2006 Aug 8]. Available from http://www.cjd.ed.ac.uk/ figures.htm
25. Clarke P, Ghani AC. Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility. Journal of the Royal Society Interface. 2005;2:19-31.
26. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmission to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 1997;389:498-501.
27. Bruce M, Chree A, Williams ES, Fraser H. Perivascular PrP amyloid in the brains of mice infected with chronic wasting disease. Brain Pathol. 2000;10:662-3.
28. Race RE, Raines A, Baron TGM, Miller MW, Jenny A, Williams ES. Comparison of abnormal prion protein glycoform patterns from transmissible spongiform encephalopathy agent-infected deer, elk, sheep, and cattle. J Virol. 2002;76:12365-8.
29. Hamir AN, Kunkle RA, Cutlip RC, Miller JM, O'Rourke KI, Williams ES, et al. Experimental transmission of chronic wasting disease agent to cattle by the intracerebral route. J Vet Diagn Invest. 2005;17:276-81.
30. Bosque PJ. Bovine spongiform encephalopathy, chronic wasting disease, scrapie, and the threat to humans from prion disease epizootics. Curr Neurol Neurosci Rep. 2002;2:488-95.
31. Majeed A, Lehmann P, Kirby L, Coleman MP. Mortality from dementias and neurodegenerative disorders in people aged 15-64 in England and Wales in 1979-96. BMJ. 1998;317:320-1.
32. Collinge J, Rossor M. A new variant of prion disease. Lancet. 1996;347:916-7.
33. National Creutzfeldt-Jakob Disease Surveillance Unit. Incidence of variant Creutzfeldt-Jakob disease onsets and deaths in the UK, January 1994-December 2004 [cited 2006 Aug 8]. Available from http://www.cjd.ed.ac.uk/ vcjdq.htm
34. Colorado Demography Office. Population totals [cited 2006 Aug 8]. Available from http://dola.colorado.gov/demog
35. National Creutzfeldt-Jakob Disease Surveillance Unit. Creutzfeldt-Jakob disease surveillance in the UK, twelfth annual report, 2003 [cited 2006 Aug 8]. Available from http://www.cjd.ed.ac.uk/twelfth/rep2003.htm
36. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586-91.
37. Colorado Demography Office. Population by age and gender [cited 2006 Aug 8]. Available from http://dola.colarado.gov/demog/CreateTable1.cfm